Loading…

MilliporeSigma launched a new high-purity synthetic cholesterol product for mRNA therapeutics, nine months ahead of schedule, increasing capacity by 50 times.
“With the introduction of our new SAFC® synthetic cholesterol product, we have increased our capacity by 50 times, helping biomanufacturers bring lifesaving therapies to patients faster.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.